http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102012212749-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79b5f9d76648dfc226a261cfb970de9c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09D11-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09D11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B41M5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09D11-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09D11-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09D11-00
filingDate 2012-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a34d9e549bc18fff3f6e6de5af1f3cf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e62a9a7d6e956390bd048ba9ddce3d0a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_307396f87bc21ad8ea143711b0a93bc6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdfd81b62649087af9e182cca89d4751
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a17507205fbee8532a5e521bd29a4cb1
publicationDate 2013-02-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DE-102012212749-A1
titleOfInvention SOLID PHASE CHANGE INK COMPOSITIONS, COMPRISING OXAZOLINE
abstract A solid ink composition comprising at least one crystalline oxazoline compound and at least one amorphous polyol-derived component and a colorant, and an optional viscosity modifier suitable for ink-jet printing, including printing on coated paper substrates. In embodiments, the solid ink formulation comprises a mixture of an amorphous and a crystalline component which imparts excellent stability to a solid ink in forming images or printing on coated paper substrates.
priorityDate 2011-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5698017-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5817169-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16767
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414886687
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419530015
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409432810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455501249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455500969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8442
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62815
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454984946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593414
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6051
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456988599
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410506103
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455587462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414863366
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521519
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105034
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457630265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457834276
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457419056
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68157
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414880692

Total number of triples: 52.